• Aprotinin (BPTI) in Red Blood Cell Membrane Biomechanics ...

  2025-09-26

  Explore the advanced role of aprotinin as a serine protease inhibitor in modulating red blood cell membrane biomechanics, surgical bleeding control, and cardiovascular disease research. This article uniquely integrates membrane biophysics and protease signaling for a fresh scientific perspective.

• EZ Cap™ Human PTEN mRNA (ψUTP): Precision Control of Tumo...

  2025-09-25

  Explore how EZ Cap™ Human PTEN mRNA (ψUTP) empowers researchers with precise, immune-evasive gene modulation for advanced cancer research. This article uniquely examines the intersection of mRNA stability enhancement, innate immune suppression, and next-gen delivery strategies in mRNA-based gene expression studies.

• Murine RNase Inhibitor: Unlocking Next-Gen Extracellular ...

  2025-09-24

  Explore how Murine RNase Inhibitor enhances RNA degradation prevention in advanced extracellular RNA (exRNA) research, enabling robust real-time RT-PCR and cDNA synthesis. Discover its unique oxidative resistance for reliable RNA-based molecular biology assays.

• 10 mM dNTP Mixture: Precision Substrate for Intracellular...

  2025-09-23

  Explore the critical role of the 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture as an equimolar dNTP solution for PCR and advanced DNA delivery research, with insights into optimizing nucleotide use in intracellular trafficking experiments.

• HyperScribe T7 RNA Kit: Precision Synthesis for Epitransc...

  2025-09-22

  Explore how the HyperScribe T7 High Yield RNA Synthesis Kit enables advanced epitranscriptomic studies, supporting capped, biotinylated, and modified RNA synthesis for applications such as RNA structure analysis and RNA vaccine research.

• BMN 673 (Talazoparib): Mechanistic Insights into PARP-DNA...

  2025-09-19

  This article explores the unique mechanistic actions of BMN 673 (Talazoparib), a potent PARP1/2 inhibitor, with an emphasis on its PARP-DNA complex trapping and implications for homologous recombination deficient cancer treatment. We synthesize recent evidence on the interplay between PARP inhibition and BRCA2-RAD51-mediated DNA repair, highlighting advances for small cell lung cancer research and beyond.

• Torin2: Advances in Selective mTOR Inhibition for Apoptos...

  2025-09-18

  Explore the unique properties of Torin2 as a potent, selective mTOR kinase inhibitor for cancer research and apoptosis assays. This article examines Torin2’s molecular selectivity, its role in mTOR signaling pathway inhibition, and its relevance to recent programmed cell death discoveries.

• For patients who have taken

  2025-03-03

  

  For patients who have taken advantage of the anti-TKIs and whose follow-up has been succeeded, some partial response has been noticed with 45% (9/20) for gefitinib, 39% (9/23) for erlotinib and 56.5% (13/23) for crizotinib. A disease progression has also been observed with 35% (7/20) for gefitinib,

• According to their structures and substrate

  2025-03-03

  

  According to their structures and substrate specificity, MMPs are divided into five major groups: collagenases (e.g., MMP1), gelatinases (e.g., MMP2, MMP9), stromelysins (e.g., MMP3, MMP10), matrilysins (e.g., MMP7), and membrane-type MMPs [7]. Among them, MMP1 is a major collagenase that degrades t

• Interestingly our transgenic mouse model with

  2025-03-03

  

  Interestingly, our transgenic mouse model with macrophages expressing AdipoR1 showed not only improved insulin sensitivity and inflammation in skeletal muscle and adipose tissues, but fat mass, macrophage and plasma lipid accumulation and foam cell formation was also favorably reduced resulting from

• A previous study reported that the serotonergic

  2025-03-03

  

  A previous study reported that the serotonergic mechanism was involved in the psychological stress-induced alteration in synaptic plasticity in the rat hippocampal CA1 field (Matsumoto et al., 2004). Sumitaka Inoue et al. (Inoue et al., 2014) reported that pretreatment with a 5-HT1A receptor partial

• In an effort to determine if one

  2025-03-03

  

  In an effort to determine if one 5ARI was more effective than the other, the Enlarged Prostate International Comparator Study (EPICS) [17] compared treatment with finasteride and dutasteride in 1630 men over the age of 50 and concluded that after one year of treatment, both groups had statistically

• br Funding br Introduction The interest in the effects of

  2025-03-03

  

  Funding Introduction The interest in the effects of endocrine disrupting chemicals (EDCs) in the aquatic environment continues to increase over the past decade, specifically those that act on steroidogenic pathways. EDCs that include synthetic androgenic and estrogenic compounds can severely a

• Normally the activity of the lyase increases with the

  2025-03-03

  

  Normally, the activity of the 17,20-lyase increases with the onset of adrenarche [7], [8], [15]. Adrenarche has previously been perceived as a relatively sudden event, occurring physiologically between 6 and 8years of age. However, results from our laboratory clearly indicated that adrenarche is a c

• FITC, Fluorescein isothiocyanate The synthesis of compounds

  2025-03-03

  

  The synthesis of compounds in which the ethyl linker has been modified to the carbamate and urea derivatives , and is shown in . Thus the diamine was reacted with glycolic FITC, Fluorescein isothiocyanate to give the alcohol followed by Mitsunobu reaction with phthalimide to give . Deprotection

15618 records 1/1042 page Next 12345 下5页 Last page